Angel Biotechnology Holdings Plc (ABH.L)
ABH.L on London Stock Exchange
0.28GBp
9 Feb 2010
0.28GBp
9 Feb 2010
Price Change (% chg)
0.00p (+0.00%)
0.00p (+0.00%)
Prev Close
0.28p
0.28p
Open
--
--
Day's High
0.28p
0.28p
Day's Low
0.25p
0.25p
Volume
36,381,104
36,381,104
Avg. Vol
84,440,624
84,440,624
52-wk High
0.70p
0.70p
52-wk Low
0.12p
0.12p
About
Angel Biotechnology Holdings Plc (Angel) is engaged in the manufacture and supply of biologics. Angel specialises in the provision of advanced biologics (biological products); these include autologous and allogeneic cell therapy products, stem cells, cellular vaccines, specific purified natural and recombinant proteins, virus... (more)
No analyst recommendations are available for ABH.L.
Overall
| Beta: | 0.66 |
| Market Cap (Mil.): | £5.72 |
| Shares Outstanding (Mil.): | 2,081.13 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| ABH.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 1.96 | 3.76 |
| EPS (TTM): | 8.05 | -- | -- |
| ROI: | -- | 0.92 | 2.30 |
| ROE: | -- | 1.27 | 2.82 |
UPDATE 1-Angel Biotech sees strong 2010, shares jump
* Signed more than 67 pct of budgeted business for 2010 (Adds details)
Angel Biotech shares soar on 1.1 mln stg deal
LONDON, April 14 (Reuters) - British contract manufacturer Angel Biotechnology signed a 1.1 million pound ($1.62 million) deal with a Russian pharmaceutical company, sending its shares up more than 52 percent to a two-year high on Tuesday.
Earnings vs
Estimates
No consensus analysis data available.





